+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation



Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation



Interventional Cardiology Clinics 7(2): Xiii




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065276807

Download citation: RISBibTeXText

PMID: 29526295

DOI: 10.1016/j.iccl.2018.01.002


Related references

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. Journal of the American College of Cardiology 59(10): 923-929, 2012

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Clinical Cardiology 40(10): 825-831, 2017

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Expert Review of Cardiovascular Therapy 13(8): 907-914, 2015

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation. Journal of Atrial Fibrillation 6(3): 923, 2013

Transcatheter left atrial appendage occlusion in the prevention of stroke and death in patients with atrial fibrillation. Kardiologia Polska 72(11): 1127-1134, 2014

The case of stroke prevention by left atrial appendage occlusion in patients with atrial fibrillation-can we close the file?. Journal of Thoracic Disease 7(10): 1696-1698, 2015

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?. Expert Review of Cardiovascular Therapy 11(12): 1587-1589, 2013

Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation. Revue Neurologique 171(5): 426-432, 2015

Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. International Journal of Cardiology 207: 335-340, 2016

Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal. Journal of Stroke 20(3): 281-291, 2018

Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry. Eurointervention 13(13): 1603-1611, 2018

Left Atrial Appendage Occlusion for Secondary Stroke Prevention in Patients with Atrial Fibrillation: Long-Term Results. Cerebrovascular Diseases 47(3-4): 188-195, 2019

Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long-term results. Journal of Diabetes 11(1): 75-82, 2019

Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. Circulation 127(24): 2414-2423, 2013

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. Europace 16(5): 626-630, 2014